Tag: HYBRIGENICS
Aton (formerly Hybrigenics) postpones its objectives to 2025
(AOF) – The Aton group, listed under its former name of Hybrigenics, announces that as of December 31, 2023, its cash and cash equivalents amounted to 2.1 million euros, compared…
HYBRIGENICS: Minutes of the general meeting of December 21, 2023 – 12/22/2023 at 6:00 p.m.
December 22, 2023 – 6:00 p.m. – The extraordinary general meeting of ATON (formerly Hybrigenics – FR0004153930 – ALHYG) was held on Thursday, December 21, 2023 at 2:00 p.m. at…
Aton (Hybrigenics): turnover target postponed
(CercleFinance.com) – Aton (Hybrigenics) announced on Friday evening that it had postponed its target of a turnover of 60 million euros by 2025 ‘to a later financial year’, which caused…
Aton (Hybrigenics) falls after postponing its financial targets
(AOF) – The Aton group, listed under the name Hybrigenics, lost 27.69% this midday to 0.0188 euros after the announcement of the postponement of its objectives “due in particular to…
Aton (Hybrigenics): revenue target postponed – 11/20/2023 at 11:41 a.m.
(CercleFinance.com) – Aton (Hybrigenics) announced on Friday evening that it had postponed its target of a turnover of 60 million euros by 2025 ‘to a later financial year’, which caused…
Aton (Hybrigenics) falls after postponing its financial targets – 11/20/2023 at 11:43
(AOF) – The Aton group, listed under the name Hybrigenics, lost 27.69% this midday to 0.0188 euros after the announcement of the postponement of its objectives “due in particular to…
HYBRIGENICS: UPDATE ON THE SITUATION OF THE ATON GROUP (HYBRIGENICS SA) – 11/17/2023 at 6:30 p.m.
Illkirch, November 17, 2023 – 6:00 p.m. The Aton Group (Hybrigenics SA – Euronext Growth Paris – FR0004153930 – ALHYG), specialized in the medical sciences sector, announces the review of…
Hybrigenics renames itself Aton and plans to double its workforce over two years – 09/26/2023 at 6:05 p.m.
(AOF) – The listed French company Hybrigenics today announces its repositioning under the name Aton, marking the completion of the transformation begun two years ago. The company’s new visual identity…
Hybrigenics renames itself Aton and plans to double its workforce over two years
(AOF) – The listed French company Hybrigenics today announces its repositioning under the name Aton, marking the completion of the transformation begun two years ago. The company’s new visual identity…
Antibody production: Hybrigenics positions its B Cells subsidiary on the diagnostics market – 03/22/2023 at 10:51
(AOF) – Biotech Hybrigenics details in a press release the activities of B Cell Design, a biotechnology company developing artificial immunoglobulins (antibodies), acquired in November 2021, through its subsidiary Inoviem…
Hybrigenics: the title rises after a point on B Cell Design
(CercleFinance.com) – Hybrigenics rose sharply on the Paris Stock Exchange on Wednesday after taking stock of its subsidiary B Cell Design, which specializes in the development of artificial antibodies. In…
Hybrigenics: a record year of investment, a restructuring objective soon achieved – 03/15/2023 at 10:42
(AOF) – The biotech Hybrigenics announces that it “records a record year in terms of investment” while its subsidiaries have been granted 4 million euros to finalize their respective structuring…